Balice-Gordon Rita J.
SEC Form 4 insider trading activity
Balice-Gordon Rita J. has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: May 18, 2026.
On the most recent filing, Balice-Gordon Rita J. is listed as Director at COLLEGIUM PHARMACEUTICAL, INC. Inside the rolling window, Balice-Gordon Rita J. reported no open-market purchases and 1 open-market sale totaling $172K in COLL.
Companies traded
Other insiders at COLL
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$172K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Balice-Gordon Rita J. made?
Balice-Gordon Rita J. has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2025.
Which companies does Balice-Gordon Rita J. trade?
Balice-Gordon Rita J. has filed SEC Form 4 disclosures for 1 company, including COLL.
When was Balice-Gordon Rita J.'s most recent SEC Form 4 filing?
Balice-Gordon Rita J.'s most recent SEC Form 4 filing on Tracefour is dated May 18, 2026.
What is Balice-Gordon Rita J.'s total buy and sell value in the current window?
Inside the rolling retention window, Balice-Gordon Rita J. bought $0 and sold $172K based on SEC Form 4 filings.
What was Balice-Gordon Rita J.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,650 COLL shares on 2025-12-05, worth $172K, per SEC Form 4 filings.